• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤型红斑狼疮患者疾病活动及损伤的自然史

Natural history of disease activity and damage in patients with cutaneous lupus erythematosus.

作者信息

Ker Khor Jia, Teske Noelle M, Feng Rui, Chong Benjamin F, Werth Victoria P

机构信息

National Skin Centre, Singapore, Singapore; Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania.

Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas.

出版信息

J Am Acad Dermatol. 2018 Dec;79(6):1053-1060.e3. doi: 10.1016/j.jaad.2018.06.040. Epub 2018 Jun 30.

DOI:10.1016/j.jaad.2018.06.040
PMID:29969701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6234101/
Abstract

BACKGROUND

Long-term studies characterizing disease course of cutaneous lupus erythematosus (CLE) patients on standard-of-care treatments are lacking.

OBJECTIVE

We characterized and compared disease course of CLE patients using Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI).

METHODS

In total, 83 CLE patients with CLASI scores collected from ≥3 study visits within 2 years had disease activity and damage trends calculated by average change scores (ACS). Trends were classified as improved (ACS ≤-3), worsened (ACS ≥3), or stable (-3 < ACS < 3). Linear regression models compared CLASI trends between groups.

RESULTS

Most patients (72.73%) with initial CLASI activity (CLASI-A) scores >9 (N = 33) had improved disease activity versus 14.00% of those with initial CLASI-A scores ≤9 (N = 50). Linear regression analyses showed significant improvement in CLASI-A scores in patients of minority races (P < .05), with baseline CLASI-A scores >9 (P < .0001), baseline CLASI damage (CLASI-D) scores ≥10 (P = .0001), and CLE disease duration ≤1 year (P = .01). Of 28 patients with baseline CLASI-D scores ≥10, 35.71% had improvements in damage, while 5.26% of patients with initial CLASI-D scores of 5-9 (N = 19) and 0% with initial CLASI-D scores <5 (N = 36) (P = .0005) had improvements.

LIMITATIONS

Limitations include small sample size.

CONCLUSION

Baseline CLASI-A score >9, minority race, and short disease duration predict CLE disease activity improvement. A baseline CLASI-D score ≥10 is associated with disease damage improvement.

摘要

背景

缺乏关于接受标准治疗的皮肤红斑狼疮(CLE)患者疾病进程的长期研究。

目的

我们使用皮肤红斑狼疮疾病面积和严重程度指数(CLASI)对CLE患者的疾病进程进行了特征描述和比较。

方法

共有83例在2年内≥3次研究访视时收集了CLASI评分的CLE患者,通过平均变化评分(ACS)计算疾病活动度和损伤趋势。趋势分为改善(ACS≤-3)、恶化(ACS≥3)或稳定(-3<ACS<3)。线性回归模型比较了各组之间的CLASI趋势。

结果

初始CLASI活动度(CLASI-A)评分>9(N = 33)的大多数患者(72.73%)疾病活动度得到改善,而初始CLASI-A评分≤9(N = 50)的患者中这一比例为14.00%。线性回归分析显示,少数族裔患者(P<0.05)、基线CLASI-A评分>9(P<0.0001)、基线CLASI损伤(CLASI-D)评分≥10(P = 0.0001)以及CLE病程≤1年(P = 0.01)的患者,其CLASI-A评分有显著改善。在28例基线CLASI-D评分≥10的患者中,35.71%的患者损伤得到改善,而初始CLASI-D评分为5-9(N = 19)的患者中有5.26%得到改善,初始CLASI-D评分<5(N = 36)的患者中改善比例为0%(P = 0.0005)。

局限性

局限性包括样本量小。

结论

基线CLASI-A评分>9、少数族裔以及疾病病程短可预测CLE疾病活动度改善。基线CLASI-D评分≥10与疾病损伤改善相关。

相似文献

1
Natural history of disease activity and damage in patients with cutaneous lupus erythematosus.皮肤型红斑狼疮患者疾病活动及损伤的自然史
J Am Acad Dermatol. 2018 Dec;79(6):1053-1060.e3. doi: 10.1016/j.jaad.2018.06.040. Epub 2018 Jun 30.
2
Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus.评估红斑狼疮患者临床改善的稳健性测量方法。
Lupus Sci Med. 2020 Jan 27;7(1):e000364. doi: 10.1136/lupus-2019-000364. eCollection 2020.
3
The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.皮肤红斑狼疮疾病面积和严重程度指数:一种用于测量皮肤红斑狼疮患者活动度和损伤情况的敏感工具。
Arch Dermatol. 2008 Feb;144(2):173-80. doi: 10.1001/archderm.144.2.173.
4
The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.研究印度系统性红斑狼疮患者的皮肤红斑狼疮疾病面积和严重程度指数。
Lupus. 2011 Dec;20(14):1510-7. doi: 10.1177/0961203311418789. Epub 2011 Oct 13.
5
The impact of skin damage due to cutaneous lupus on quality of life.皮肤狼疮导致的皮肤损伤对生活质量的影响。
Br J Dermatol. 2014 Feb;170(2):315-21. doi: 10.1111/bjd.12653.
6
Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI.使用 CLASI 评估不同亚型的红斑狼疮皮肤疾病活动度和损伤。
J Eur Acad Dermatol Venereol. 2011 Jun;25(6):652-9. doi: 10.1111/j.1468-3083.2010.03844.x. Epub 2010 Sep 16.
7
Clinicohistological and immunopathological features of patients with cutaneous lupus erythematosus at tertiary dermatology centre in Malaysia.马来西亚一家三级皮肤科中心的皮肤红斑狼疮患者的临床组织学和免疫病理学特征。
Clin Exp Dermatol. 2022 Aug;47(8):1490-1501. doi: 10.1111/ced.15190. Epub 2022 May 23.
8
Impact of smoking in cutaneous lupus erythematosus.吸烟对皮肤型红斑狼疮的影响。
Arch Dermatol. 2012 Mar;148(3):317-22. doi: 10.1001/archdermatol.2011.342. Epub 2011 Nov 21.
9
Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures.使用医生和患者评估的健康结局测量来验证皮肤狼疮疾病面积和严重程度指数 (CLASI)。
J Am Acad Dermatol. 2013 Apr;68(4):618-623. doi: 10.1016/j.jaad.2012.08.035. Epub 2012 Oct 26.
10
Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain.皮肤红斑狼疮:西班牙拉科鲁尼亚 260 例患者的皮肤活动和损害相关因素。
Lupus. 2020 Aug;29(9):1021-1030. doi: 10.1177/0961203320930094. Epub 2020 Jun 15.

引用本文的文献

1
Smoking status is a negative predictor of six-month cutaneous lupus activity trends: A prospective cohort study.吸烟状况是六个月皮肤狼疮活动趋势的负向预测指标:一项前瞻性队列研究。
J Am Acad Dermatol. 2025 Apr;92(4):912-914. doi: 10.1016/j.jaad.2024.11.056. Epub 2024 Dec 6.
2
Association of the Spectrum of Cutaneous Lupus Erythematosus with Disease Activity and Systemic Manifestations in Patients with Systemic Lupus Erythematosus.系统性红斑狼疮患者皮肤红斑狼疮谱与疾病活动及全身表现的关联
Mediterr J Rheumatol. 2023 Sep 19;35(1):143-149. doi: 10.31138/mjr.200423.aos. eCollection 2024 Mar.
3
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.

本文引用的文献

1
Cutaneous dermatomyositis disease course followed over time using the Cutaneous Dermatomyositis Disease Area and Severity Index.根据皮肤肌炎疾病面积和严重程度指数,对皮肤肌炎疾病随时间推移的病程进行跟踪。
J Am Acad Dermatol. 2018 Sep;79(3):464-469.e2. doi: 10.1016/j.jaad.2017.10.022. Epub 2017 Oct 21.
2
Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database.吸烟对红斑狼疮患者疾病严重程度和抗疟治疗的影响:EUSCLE 数据库中 1002 例患者的分析。
Br J Dermatol. 2014 Sep;171(3):571-9. doi: 10.1111/bjd.13006. Epub 2014 Aug 25.
3
皮肤红斑狼疮:发病机制及未来治疗方向的最新进展。
Am J Clin Dermatol. 2023 Jul;24(4):521-540. doi: 10.1007/s40257-023-00774-8. Epub 2023 May 4.
4
Influence of Socio-Demographic Factors in Patients With Cutaneous Lupus Erythematosus.社会人口学因素对皮肤型红斑狼疮患者的影响。
Front Med (Lausanne). 2022 Jul 11;9:916134. doi: 10.3389/fmed.2022.916134. eCollection 2022.
5
Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need.制定一个用于红斑狼疮性皮肤病的工作核心结局集:满足一个急迫未满足需求的实用方法。
Lupus Sci Med. 2021 Dec;8(1). doi: 10.1136/lupus-2021-000529.
6
Modular gene analysis reveals distinct molecular signatures for subsets of patients with cutaneous lupus erythematosus.模块化基因分析揭示了不同亚组的盘状红斑狼疮患者的独特分子特征。
Br J Dermatol. 2021 Sep;185(3):563-572. doi: 10.1111/bjd.19800. Epub 2021 Mar 3.
7
Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus.评估红斑狼疮患者临床改善的稳健性测量方法。
Lupus Sci Med. 2020 Jan 27;7(1):e000364. doi: 10.1136/lupus-2019-000364. eCollection 2020.
The impact of skin damage due to cutaneous lupus on quality of life.
皮肤狼疮导致的皮肤损伤对生活质量的影响。
Br J Dermatol. 2014 Feb;170(2):315-21. doi: 10.1111/bjd.12653.
4
Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.盘状红斑狼疮与多种族狼疮队列中临床表现和损害累积的相关性。
Arthritis Care Res (Hoboken). 2012 May;64(5):704-12. doi: 10.1002/acr.21581.
5
Impact of smoking in cutaneous lupus erythematosus.吸烟对皮肤型红斑狼疮的影响。
Arch Dermatol. 2012 Mar;148(3):317-22. doi: 10.1001/archdermatol.2011.342. Epub 2011 Nov 21.
6
Response to hydroxychloroquine in Japanese patients with systemic lupus erythematosus using the cutaneous lupus erythematosus disease area and severity index (CLASI).基于皮肤红斑狼疮疾病面积和严重指数(CLASI)评估羟氯喹治疗日本系统性红斑狼疮患者的疗效。
Mod Rheumatol. 2012 Apr;22(2):249-55. doi: 10.1007/s10165-011-0503-y. Epub 2011 Aug 14.
7
Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis.皮肤红斑狼疮对抗疟药的反应:一项前瞻性分析。
Arch Dermatol. 2011 Nov;147(11):1261-7. doi: 10.1001/archdermatol.2011.191. Epub 2011 Jul 18.
8
Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus.脉冲染料激光治疗皮肤盘状红斑狼疮的疗效和安全性。
J Am Acad Dermatol. 2009 Apr;60(4):626-32. doi: 10.1016/j.jaad.2008.11.904.
9
Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.肿胀性红斑狼疮:36例患者对抗疟治疗的反应,重点关注吸烟情况
Arch Dermatol. 2009 Mar;145(3):244-8. doi: 10.1001/archdermatol.2008.592.
10
The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.皮肤红斑狼疮疾病面积和严重程度指数:一种用于测量皮肤红斑狼疮患者活动度和损伤情况的敏感工具。
Arch Dermatol. 2008 Feb;144(2):173-80. doi: 10.1001/archderm.144.2.173.